Market cap
$312 Mln
Revenue (TTM)
$215 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-5.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.6
-
Face value
--
-
Shares outstanding
20,969,109
10 Years Aggregate
CFO
$-627.25 Mln
EBITDA
$-519.79 Mln
Net Profit
$-640.29 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amarin (AMRN)
| 6.3 | 1.4 | 5.3 | 45.6 | -18.9 | -30.4 | -6.9 |
|
BSE Sensex*
| -8.7 | 3.6 | -7.5 | -4.2 | 8.2 | 9.5 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Amarin (AMRN)
| 43.9 | -44.0 | -28.1 | -64.1 | -31.1 | -77.2 | 57.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amarin (AMRN)
|
14.8 | 312.4 | 214.9 | -33.6 | -2.4 | -7.4 | -- | 0.7 |
| 27.5 | 1,604.5 | 66.1 | -422.6 | -720.0 | -35.3 | -- | 0.7 | |
| 7.0 | 1,753.9 | 427.7 | -58.1 | -9.0 | -38.3 | -- | 12.2 | |
| 21.4 | 1,082.3 | 412.8 | -8.2 | -2.6 | -2.6 | -- | 3.5 | |
| 14.1 | 908.8 | 0.0 | -69.7 | -- | -33.4 | -- | 3.8 | |
| 84.6 | 7,095.5 | 51.5 | -315.1 | -477.7 | -25.3 | -- | 4.5 | |
| 428.7 | 12,189.0 | 2,678.3 | 460.4 | 21.1 | 103.2 | 26.9 | 19.9 | |
| 12.2 | 1,010.5 | 204.9 | -157.3 | -39.6 | -- | -- | 25.4 | |
| 20.5 | 1,829.8 | 217.2 | -243.3 | -31.2 | -309.8 | -- | 42.5 | |
| 31.6 | 3,747.9 | 0.0 | -472.3 | -- | -77.8 | -- | 7.3 |
Shareholding Pattern
View DetailsAbout Amarin (AMRN)
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only... omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: One Central Plaza, Dublin, Ireland, D02 K7K5 Read more
-
President, CEO & Director
Mr. Patrick J. Holt
-
President, CEO & Director
Mr. Patrick J. Holt
-
Headquarters
Dublin
-
Website
FAQs for Amarin (AMRN)
What is the current share price of Amarin Corporation plc (AMRN) Today?
The share price of Amarin Corporation plc (AMRN) is $14.84 (NASDAQ) as of 07-May-2026 16:00 EDT. Amarin Corporation plc (AMRN) has given a return of -18.88% in the last 3 years.
What is the current PB & PE ratio of Amarin Corporation plc (AMRN)?
Since, TTM earnings of Amarin Corporation plc (AMRN) is negative, P/E ratio is not available.
The P/B ratio of Amarin Corporation plc (AMRN) is 0.67 times as on 07-May-2026, a 85 discount to its peers’ median range of 4.45 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-7.48
|
0.63
|
|
2024
|
-0.12
|
0.02
|
|
2023
|
-0.30
|
0.03
|
|
2022
|
-0.23
|
0.04
|
|
2021
|
8.76
|
0.10
|
What is the 52 Week High and Low of Amarin Corporation plc (AMRN)?
The 52-week high and low of Amarin Corporation plc (AMRN) are Rs 20.90 and Rs 9.44 as of 08-May-2026.
What is the market cap of Amarin Corporation plc (AMRN)?
Amarin Corporation plc (AMRN) has a market capitalisation of $ 312 Mln as on 07-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Amarin Corporation plc (AMRN)?
Before investing in Amarin Corporation plc (AMRN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.